Skip to main page content

Guideline

. 2009 Jul 21:339:b2535.

doi: 10.1136/bmj.b2535.

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

David Moher¹, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman; PRISMA Group

Collaborators, Affiliations

Collaborators

Affiliation

¹ Ottawa Methods Centre, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. dmoher@ohri.ca

PMID: 19622551
PMCID: PMC2714657
DOI: 10.1136/bmj.b2535

Guideline

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

David Moher et al. BMJ. 2009.

. 2009 Jul 21:339:b2535.

doi: 10.1136/bmj.b2535.

Authors

David Moher¹, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman; PRISMA Group

Collaborators

Affiliation

¹ Ottawa Methods Centre, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. dmoher@ohri.ca

PMID: 19622551
PMCID: PMC2714657
DOI: 10.1136/bmj.b2535

Abstract

David Moher and colleagues introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

None — Flow of information through the different phases of a systematic review.

See this image and copyright information in PMC

Comment in

Association between maternal age at conception and risk of idiopathic clubfoot.
Liu YB, Zhao L, Ding J, Zhu J, Xie CL, Wu ZK, Yang X, Li H. Liu YB, et al. Acta Orthop. 2016 Jun;87(3):291-5. doi: 10.3109/17453674.2016.1153359. Epub 2016 Feb 22. Acta Orthop. 2016. PMID: 26901038 Free PMC article.

Similar articles

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Moher D, et al. Ann Intern Med. 2009 Aug 18;151(4):264-9, W64. doi: 10.7326/0003-4819-151-4-200908180-00135. Epub 2009 Jul 20. Ann Intern Med. 2009. PMID: 19622511 No abstract available.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Moher D, et al. PLoS Med. 2009 Jul 21;6(7):e1000097. doi: 10.1371/journal.pmed.1000097. Epub 2009 Jul 21. PLoS Med. 2009. PMID: 19621072 Free PMC article. No abstract available.
Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Moher D, et al. Phys Ther. 2009 Sep;89(9):873-80. Phys Ther. 2009. PMID: 19723669 No abstract available.
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. Liberati A, et al. BMJ. 2009 Jul 21;339:b2700. doi: 10.1136/bmj.b2700. BMJ. 2009. PMID: 19622552 Free PMC article.
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. Liberati A, et al. J Clin Epidemiol. 2009 Oct;62(10):e1-34. doi: 10.1016/j.jclinepi.2009.06.006. Epub 2009 Jul 23. J Clin Epidemiol. 2009. PMID: 19631507

See all similar articles

Cited by

Combination of pemetrexed with bevacizumab for non-small-cell lung cancer: a meta-analysis study.
Fang W, Peng X, Zhou Q. Fang W, et al. J Cardiothorac Surg. 2024 Aug 2;19(1):478. doi: 10.1186/s13019-024-02975-6. J Cardiothorac Surg. 2024. PMID: 39090722
Comparison of lung volumes measured with computed tomography and whole-body plethysmography - a systematic review.
Olsen HJB, Mortensen J. Olsen HJB, et al. Eur Clin Respir J. 2024 Jul 29;11(1):2381898. doi: 10.1080/20018525.2024.2381898. eCollection 2024. Eur Clin Respir J. 2024. PMID: 39081799 Free PMC article. Review.
Direct oral anticoagulants in embolic stroke of undetermined source: an updated meta-analysis.
Marinheiro G, Araújo B, Rivera A, Monteiro GA, Santana LS, Leite M, Mutarelli A, Pinheiro AC, Figueiredo EG, Telles JPM. Marinheiro G, et al. J Thromb Thrombolysis. 2024 Jul 29. doi: 10.1007/s11239-024-03017-7. Online ahead of print. J Thromb Thrombolysis. 2024. PMID: 39078535 Review.
Direct Oral Anticoagulants versus Vitamin K Antagonists for the Treatment of Left Ventricular Thrombosis: A Meta-Analysis.
Li J, Hu Y, Wu Z. Li J, et al. Rev Cardiovasc Med. 2022 Sep 13;23(9):312. doi: 10.31083/j.rcm2309312. eCollection 2022 Sep. Rev Cardiovasc Med. 2022. PMID: 39077723 Free PMC article.
Timing of Complete Revascularization in Patients with STEMI and Multivessel Disease: A Systematic Review and Meta-Analysis.
Panuccio G, Salerno N, De Rosa S, Torella D. Panuccio G, et al. Rev Cardiovasc Med. 2023 Feb 10;24(2):58. doi: 10.31083/j.rcm2402058. eCollection 2023 Feb. Rev Cardiovasc Med. 2023. PMID: 39077406 Free PMC article.

See all "Cited by" articles

References

1. Oxman AD, Cook DJ, Guyatt GH. Users’ guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group. JAMA 1994;272:1367-71. - PubMed
1. Swingler GH, Volmink J, Ioannidis JP. Number of published systematic reviews and global burden of disease: database analysis. BMJ 2003;327:1083-4. - PMC - PubMed
1. Canadian Institutes of Health Research. Randomized controlled trials registration/application checklist (12/2006). 2006. www.cihr-irsc.gc.ca/e/documents/rct_reg_e.pdf (accessed 19 May 2009).
1. Young C, Horton R. Putting clinical trials into context. Lancet 2005;366:107. - PubMed
1. Mulrow CD. The medical review article: state of the science. Ann Intern Med 1987;106:485-8. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations